Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Gamma-Aminobutyric Acid and Kynurenic Acid

Research Papers that Mention the Interaction

Interestingly, kynA inhibited the peak amplitude (IC(50): 2.9 mM for 10 muM GABA ) and slowed the decay kinetics of GABA-evoked currents in cultured neurons.
Neuropharmacology  •  2009  |  View Paper
Glutamate stimulates dopamine release by NMDA receptors, while blockade with kynurenic acid prevented the increase in dopamine and, in turn, of GABA and glutamate.
Biomolecules  •  2019  |  View Paper
Applied to awake rats for 2 h by reverse dialysis, KYNA concentration-dependently and reversibly reduced extracellular GABA levels, with 300 nM KYNA causing a nadir of ∼45% of baseline concentrations.
Neuropharmacology  •  2014  |  View Paper
KYNA concentration‐dependently reduced GABA levels, with 300 nm KYNA causing a maximal reduction to ~60% of baseline concentrations.
The European journal of neuroscience  •  2013  |  View Paper
Although significant changes in baseline arterial pressure and inspiratory activity were observed after topical applications of KYN and GABA , there are no guarantees that these treatments on the dorsal medulla were effective in depressing all neuronal activity at the NTS level.
This issue becomes more evident if it is considered that KYN and GABA applications on the dorsal surface of the medulla produced opposite effects on the arterial pressure.
The Journal of physiology  •  2008  |  View Paper